Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2002 Canadian Stock-Picking Challenge -- Ignore unavailable to you. Want to Upgrade?

To: Shack who wrote (45)	12/25/2001 10:33:33 AM
From: Al Collard	Respond to of 1590

Shack, Yes you can change your pick right up to and including Jan 1st 2002.

To: Shack who wrote (45)	1/1/2002 2:51:51 PM
From: Al Collard	Respond to of 1590

Hi Shack, Your in with VAS-t @$7.35 for 2,721 shares. Chart for Vasogen, Inc: stockcharts.com[w,a]djcaniay[dc][pc20!b50!b100!b200!f][vc60][iUb14!Ll14!La12,26,9!Lh14,3!Lc20] Good luck in the 2002 Canadian Stock-Picking Challenge. May all your 2002 trades be profitable. Regards, Al

To: Shack who wrote (45)	2/4/2002 10:29:26 AM
From: Al Collard	Respond to of 1590

VAS-t...in the news: Vasogen to Conduct Year-end Conference Call newswire.ca

To: Shack who wrote (45)	2/7/2002 7:45:25 AM
From: Al Collard	Respond to of 1590

VAS-t...in the news: Vasogen Announces 2001 Year-End Results newswire.ca

To: Shack who wrote (45)	2/28/2002 12:11:36 AM
From: Al Collard	Read Replies (3) \| Respond to of 1590

VAS-t...in the news: Vasogen Announces Positive Results from Congestive Heart Failure Trial newswire.ca

To: Shack who wrote (45)	3/6/2002 8:05:38 AM
From: Al Collard	Respond to of 1590

VAS-t...in the news: Vasogen Appoints the President of Quest Diagnostics to its Board of Directors newswire.ca

To: Shack who wrote (45)	4/11/2002 11:26:25 AM
From: Al Collard	Respond to of 1590

VAS-t...in the news: Vasogen Announces First Quarter 2002 Results newswire.ca

To: Shack who wrote (45)	5/7/2002 11:06:22 AM
From: Al Collard	Respond to of 1590

Vasogen Announces $17 Million Bought Deal newswire.ca

To: Shack who wrote (45)	5/24/2002 7:50:27 AM
From: Al Collard	Respond to of 1590

VAS-t...in the news: Vasogen Announces Exercise of Underwriters' Option newswire.ca

To: Shack who wrote (45)	6/10/2002 2:03:01 PM
From: Al Collard	Read Replies (1) \| Respond to of 1590

VAS-t...in the news: Vasogen Announces Plans for North American Pivotal Trial in Chronic Heart Failure newswire.ca

To: Shack who wrote (45)	9/4/2002 11:02:29 AM
From: Al Collard	Respond to of 1590

VAS-t...in the news: Vasogen Clinical Results in Heart Failure Selected for Oral Presentation at the 2002 Scientific Sessions of the American Heart Association newswire.ca

To: Shack who wrote (45)	9/25/2002 10:24:38 AM
From: Al Collard	Respond to of 1590

VAS-t...in the news: Vasogen's Clinical Results Presented at the Scientific Meeting of the Heart Failure Society of America http://www.newswire.ca/releases/September2002/25/c4506.html